Jeremy Slessman

Jeremy is our Vice President of Quality.

He has over 20 years of experience providing quality oversight for both clinical development and commercial manufacturing. Most recently, he was Vice President of Quality Systems at TG Therapeutics where he was responsible for leading the design, development, implementation, and continuous improvement of the TG quality management system and providing quality oversight of external suppliers and service providers. Prior to that, he led a global quality control operations team at Biogen and held leadership roles in both Quality Systems and Quality Control at Eisai. Earlier in his career, he was an analytical scientist responsible for method development, validation, and transfers at Cardinal Health Pharmaceutical Development.

He received a BS in Chemistry from the University of North Carolina at Chapel Hill.